Hypoxic regions exist in human prostate carcinoma

被引:140
作者
Movsas, B
Chapman, JD
Horwitz, EM
Pinover, WH
Greenberg, RE
Hanlon, AL
Iyer, R
Hanks, GE
机构
[1] Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Dept Surg Oncol, Philadelphia, PA 19111 USA
关键词
D O I
10.1016/S0090-4295(98)00500-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The purpose of this study was to characterize, by use of the Eppendorf microelectrode, the extent of hypoxia (range/heterogeneity) in human prostate carcinomas, Methods. Custom-made Eppendorf pO(2) microelectrodes were used to obtain pO(2) measurements from the pathologically involved side of the prostate, as well as from a region of normal muscle for comparison. Each set of measurements comprised approximately 100 separate readings of pO(2), for a total of 2145 individual measurements. Twelve patients were studied, 7 of whom underwent brachytherapy, 3 a radical prostatectomy, and 2 a cystoprostatectomy. The pO(2) measurements were obtained in the operating room, using sterile technique, under spinal anesthesia for the brachytherapy group patients and under general anesthesia for the surgery group patients. The Eppendorf histograms were recorded and described by the median pO(2), mean pO(2), and percentage of measurements less than 5 mm Hg and less than 10 mm Hg. Results, Because of differences in patient characteristics and the anesthesia employed, control measurements were obtained from nearby normal muscle as an internal control in all but 2 patients. This internal comparison showed that the oxygen measurements from the pathologically involved portion of the prostate were significantly lower than those from normal muscle. Similarly, higher pO(2) readings were obtained from the pathologically normal prostates (in the patients with bladder cancer) than from the prostates of patients with prostate carcinoma. Increasing levels of hypoxia were observed with increasing clinical stage. Significant predictors of oxygenation include the type of tissue (pathologically involved prostate versus normal muscle or normal prostate), clinical stage, and type of anesthesia. Conclusions. This report, to our knowledge, represents the first study to obtain in vivo electrode measurements of oxygen levels in patients with prostate cancer and suggests that hypoxic regions exist in human prostate carcinoma. More patients will be accrued to this prospective study to correlate the oxygenation status of prostate carcinoma with known prognostic factors and treatment outcome. UROLOGY 53: 11-18, 1999. (C) 1999, Elsevier Science Inc. All rights reserved.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 27 条
[1]   Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck [J].
Brizel, DM ;
Sibley, GS ;
Prosnitz, LR ;
Scher, RL ;
Dewhirst, MW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (02) :285-289
[2]   TUMOR HYPOXIA - THE PICTURE HAS CHANGED IN THE 1990S [J].
BROWN, JM ;
GIACCIA, AJ .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1994, 65 (01) :95-102
[3]   Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays [J].
Chapman, JD ;
Engelhardt, EL ;
Stobbe, CC ;
Schneider, RF ;
Gerald, GE .
RADIOTHERAPY AND ONCOLOGY, 1998, 46 (03) :229-237
[4]  
CRUICKSHANK GS, 1994, ADV EXP MED BIOL, V345, P465
[5]   OXYGEN DISTRIBUTION IN SQUAMOUS-CELL CARCINOMA METASTASES AND ITS RELATIONSHIP TO OUTCOME OF RADIATION-THERAPY [J].
GATENBY, RA ;
KESSLER, HB ;
ROSENBLUM, JS ;
COIA, LR ;
MOLDOFSKY, PJ ;
HARTZ, WH ;
BRODER, GJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (05) :831-838
[6]  
GROSHAR D, 1993, J NUCL MED, V34, P885
[7]   Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions [J].
Hanks, GE ;
Hanlon, AL ;
Schultheiss, TE ;
Pinover, WH ;
Movsas, B ;
Epstein, BE ;
Hunt, MA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (03) :501-510
[8]  
HANKS GE, 1993, INT J RADIAT ONCOL, V28, P39
[9]  
HANKS GE, 1995, 5 INT M PROGR RAD MA
[10]  
Hockel M, 1996, CANCER RES, V56, P4509